Skip to main content

Table 2 Comparison of life quality scale EORTC QLQ-C30 scores between groups

From: Evaluation of clinical efficacy, adverse reactions, and safety of PD-1 inhibitors combined with chemotherapy when treating advanced gastric cancer

  

Control group

Research group

P

Symptom score

Before treatment

42.4 ± 5.0

42.7 ± 5.2

0.812

 

After treatment

29.8 ± 5.0

27.1 ± 3.3

0.003

Functional score

Before treatment

23.3 ± 3.3

23.8 ± 3.0

0.426

 

After treatment

32.8 ± 2.5

40.2 ± 3.3

< 0.001

Total health score

Before treatment

3.1 ± 0.3

3.2 ± 0.3

0.490

 

After treatment

5.7 ± 1.0

7.1 ± 1.1

< 0.001